Abstract: The present invention relates to a method for the early diagnosis of cancer in a subject, which is based on determination of the relative fraction of microorganisms derived from the feces of the subject, as compared to the total count of microorganisms in the same of corresponding sample. This relation has been found to be indicative of the presence or absence of cancer in said subject. After isolating at least one of the microorganisms from the fecal sample to form a so-called diagnostic sample, and incubating, for a sufficient time, the diagnostic sample with cancer cells. The microorganism being in an amount corresponding to its relative fraction in the original fecal sample, the cancerolytic activity of the microorganism/s is indicative to the presence or absence of cancer cells in the subject. The cancerolytic activity is expressed by terms of a tumor cell necrosis index (TCNI).
Type:
Grant
Filed:
August 9, 2001
Date of Patent:
November 11, 2008
Assignee:
Era-Massis, Inc.
Inventors:
Gil Tenne, Mark L. Levitt, Anahit Karapetian
Abstract: The present invention relates to a method for the early diagnosis of cancer in a subject, which is based on determination of the relative fraction of microorganisms derived from the feces of the sublect, as compared to the total count of microorganisms in the same of corresponding sample. This relation has been found to be indicative of ihe presence or absence of cancer in said subject.
Type:
Application
Filed:
August 9, 2001
Publication date:
March 6, 2003
Applicant:
ERA-MASSIS, INC.
Inventors:
Gil Tenne, Mark L. Levitt, Anahit Karapetian